loading page

The anti-IgE autoantibodies are biomarkers of early omalizumab response in patients with chronic spontaneous urticaria
  • +7
  • Yusuke Niwa,
  • Koremasa Hayama,
  • Shota Toyoshima,
  • Keisuke Shimizu,
  • Maho Tagui,
  • Mana Ito,
  • Tomomi Sasaki-Sakamoto,
  • Tadashi Terui,
  • Hideki Fujita,
  • Yoshimichi Okayama
Yusuke Niwa
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Gekakei
Author Profile
Koremasa Hayama
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Gekakei
Author Profile
Shota Toyoshima
Nihon Ika Daigaku Fuzoku Byoin
Author Profile
Keisuke Shimizu
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Gekakei
Author Profile
Maho Tagui
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Gekakei
Author Profile
Mana Ito
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Gekakei
Author Profile
Tomomi Sasaki-Sakamoto
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Naikakei
Author Profile
Tadashi Terui
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Gekakei
Author Profile
Hideki Fujita
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Gekakei
Author Profile
Yoshimichi Okayama
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Naikakei

Corresponding Author:[email protected]

Author Profile
Submitted to Allergy
Submission Checks Completed
Assigned to Editor
Reviewer(s) Assigned
26 Jun 2024Review(s) Completed, Editorial Evaluation Pending
30 Jun 2024Reviewer(s) Assigned
15 Jul 2024Editorial Decision: Revise Minor
01 Nov 20241st Revision Received
07 Nov 2024Submission Checks Completed
07 Nov 2024Assigned to Editor
07 Nov 2024Review(s) Completed, Editorial Evaluation Pending
07 Nov 2024Reviewer(s) Assigned
14 Nov 2024Editorial Decision: Accept